|
|||
2009-02-05 06:30:00 CET 2009-02-05 06:31:10 CET REGULATED INFORMATION Össur hf. - Financial Statement ReleaseOssur hf. - 2008 Full Year Report2008 Financial Highlights * Sales USD 350.0 million, up by 4% * EBITDA USD 79.4 million, up by 23% * EBITDA margin 23%, compared to 19% in 2007 * Net profit USD 28.5 million, compared to USD 7.6 million in 2007 * EPS diluted 6.73 US cents, compared to 1.94 US cents in 2007 * Cash EPS diluted 12.3 US cents, compared to 8.24 US cents in 2007 Jon Sigurdsson, President & CEO, comments:"The year was characterized by internal focus. One of our main tasks has been to increase profitability and although the sales were slower than anticipated the profits increased considerably. In 2008 we introduced thirteen new products and twenty products were discontinued. In 2009 some new and exciting products will be launched and we will focus on traditional products that fit into the current reimbursement channels. The financial crises we have seen around the world have had limited effects on the underlying business of the Company as well as the healthcare sector in general. Overall, we are confident that we have managed to build a strong Company with a solid foundation for future success." The press release including tables, the Investor Presentation Q4 2008 and the Financial Statement Q4 2008 can be downloaded from the following links: |
|||
|